Literature DB >> 22965650

Prior fundoplication does not improve safety or efficacy outcomes of radiofrequency ablation: results from the U.S. RFA Registry.

Nicholas J Shaheen1, Hannah P Kim, William J Bulsiewicz, William D Lyday, George Triadafilopoulos, Herbert C Wolfsen, Srinadh Komanduri, Gary W Chmielewski, Atilla Ertan, F Scott Corbett, Daniel S Camara, Richard I Rothstein, Bergein F Overholt.   

Abstract

BACKGROUND: Ongoing gastroesophageal reflux may impair healing and re-epithelialization after radiofrequency ablation (RFA) of Barrett's esophagus (BE). Because prior fundoplication may improve reflux control, our aim was to assess the relationship between prior fundoplication and the safety/efficacy of RFA.
METHODS: We assessed the U.S. RFA Registry, a nationwide registry of BE patients receiving RFA at 148 institutions, to compare the safety and efficacy of ablation between those with prior fundoplication and those with medical management (proton pump inhibition).
RESULTS: Among 5,537 patients receiving RFA, 301 (5.4 %) had prior fundoplication. Of fundoplication subjects, 1.0 % developed stricture and 1.0 % were hospitalized after RFA. Rates of stricture, bleeding, and hospitalization were not statistically different (p = ns) between patients with and without prior fundoplication. Complete eradication of intestinal metaplasia and complete eradication of dysplasia were achieved in 71 % and 87 % of fundoplication patients, and 73 % and 87 % of patients without fundoplication, respectively (p = ns for both). Patients with prior fundoplication needed similar numbers of RFA sessions for eradication compared with those without fundoplication.
CONCLUSIONS: Radiofrequency ablation, with or without prior fundoplication, is safe and effective in eradicating BE. Prior fundoplication was associated with similar adverse event and efficacy rates when compared with medical management.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22965650     DOI: 10.1007/s11605-012-2001-8

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  27 in total

1.  Surgical management of refractory gastro-oesophageal reflux.

Authors:  G Zaninotto; S E A Attwood
Journal:  Br J Surg       Date:  2010-02       Impact factor: 6.939

2.  Gastroesophageal reflux disease and mucosal injury with emphasis on short-segment Barrett's esophagus and duodenogastroesophageal reflux.

Authors:  S Oberg; M P Ritter; P F Crookes; M Fein; R J Mason; M Gadensytätter; C G Brenner; J H Peters; T R DeMeester
Journal:  J Gastrointest Surg       Date:  1998 Nov-Dec       Impact factor: 3.452

3.  Effects of Nissen fundoplication on endoscopic endoluminal radiofrequency ablation of Barrett's esophagus.

Authors:  Kathleen O'Connell; Vic Velanovich
Journal:  Surg Endosc       Date:  2010-07-30       Impact factor: 4.584

4.  Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation.

Authors:  E Montgomery; M P Bronner; J R Goldblum; J K Greenson; M M Haber; J Hart; L W Lamps; G Y Lauwers; A J Lazenby; D N Lewin; M E Robert; A Y Toledano; Y Shyr; K Washington
Journal:  Hum Pathol       Date:  2001-04       Impact factor: 3.466

5.  Incidence of adenocarcinoma among patients with Barrett's esophagus.

Authors:  Frederik Hvid-Jensen; Lars Pedersen; Asbjørn Mohr Drewes; Henrik Toft Sørensen; Peter Funch-Jensen
Journal:  N Engl J Med       Date:  2011-10-13       Impact factor: 91.245

6.  Circumferential and focal ablation of Barrett's esophagus containing dysplasia.

Authors:  Virender K Sharma; H Jae Kim; Ananya Das; Christopher D Wells; Cuong C Nguyen; David E Fleischer
Journal:  Am J Gastroenterol       Date:  2009-01-27       Impact factor: 10.864

7.  Persistent acid and bile reflux in asymptomatic patients with Barrett esophagus receiving proton pump inhibitor therapy.

Authors:  Abeezar I Sarela; David G Hick; Caroline S Verbeke; John F Casey; Pierre J Guillou; Geoffrey W B Clark
Journal:  Arch Surg       Date:  2004-05

8.  Small adenocarcinomas of the esophagogastric junction: association with intestinal metaplasia and dysplasia.

Authors:  Alan J Cameron; Enrico O Souto; Thomas C Smyrk
Journal:  Am J Gastroenterol       Date:  2002-06       Impact factor: 10.864

9.  Radiofrequency ablation in Barrett's esophagus with dysplasia.

Authors:  Nicholas J Shaheen; Prateek Sharma; Bergein F Overholt; Herbert C Wolfsen; Richard E Sampliner; Kenneth K Wang; Joseph A Galanko; Mary P Bronner; John R Goldblum; Ana E Bennett; Blair A Jobe; Glenn M Eisen; M Brian Fennerty; John G Hunter; David E Fleischer; Virender K Sharma; Robert H Hawes; Brenda J Hoffman; Richard I Rothstein; Stuart R Gordon; Hiroshi Mashimo; Kenneth J Chang; V Raman Muthusamy; Steven A Edmundowicz; Stuart J Spechler; Ali A Siddiqui; Rhonda F Souza; Anthony Infantolino; Gary W Falk; Michael B Kimmey; Ryan D Madanick; Amitabh Chak; Charles J Lightdale
Journal:  N Engl J Med       Date:  2009-05-28       Impact factor: 91.245

10.  Radiofrequency ablation for Barrett's esophagus and low-grade dysplasia in combination with an antireflux procedure: a new paradigm.

Authors:  Ricardo S dos Santos; Costas Bizekis; Michael Ebright; Michael DeSimone; Benedict D Daly; Hiran C Fernando
Journal:  J Thorac Cardiovasc Surg       Date:  2010-01-13       Impact factor: 5.209

View more
  18 in total

1.  Development of Evidence-Based Surveillance Intervals After Radiofrequency Ablation of Barrett's Esophagus.

Authors:  Cary C Cotton; Rehan Haidry; Aaron P Thrift; Laurence Lovat; Nicholas J Shaheen
Journal:  Gastroenterology       Date:  2018-04-13       Impact factor: 22.682

2.  Sex and race and/or ethnicity differences in patients undergoing radiofrequency ablation for Barrett's esophagus: results from the U.S. RFA Registry.

Authors:  Sarina Pasricha; Nan Li; William J Bulsiewicz; Richard I Rothstein; Anthony Infantolino; Atilla Ertan; Daniel S Camara; Evan S Dellon; George Triadafilopoulos; Charles J Lightdale; Ryan D Madanick; William D Lyday; Raman V Muthusamy; Bergein F Overholt; Nicholas J Shaheen
Journal:  Gastrointest Endosc       Date:  2015-04-01       Impact factor: 9.427

3.  Recurrence of Barrett's Esophagus is Rare Following Endoscopic Eradication Therapy Coupled With Effective Reflux Control.

Authors:  Srinadh Komanduri; Peter J Kahrilas; Kumar Krishnan; Tim McGorisk; Kiran Bidari; David Grande; Laurie Keefer; John Pandolfino
Journal:  Am J Gastroenterol       Date:  2017-02-14       Impact factor: 10.864

Review 4.  Advances in the Diagnosis and Treatment of Barrett's Esophagus and Early Esophageal Cancer; Summary of the Kelly and Carlos Pellegrini SSAT/SAGES Luncheon Symposium.

Authors:  Jon C Gould; Mark R Wendling; Brant K Oeschlager; Sumeet K Mittal; Srinadh Komanduri; Kyle A Perry; Sean Cleary; Susan Galandiuk; Daniel J Scott; P Marco Fisichella; Nicholas J Shaheen; Kelly R Haisley; John G Hunter
Journal:  J Gastrointest Surg       Date:  2017-02-27       Impact factor: 3.452

5.  The Durability of Endoscopic Therapy for Treatment of Barrett's Metaplasia, Dysplasia, and Mucosal Cancer After Nissen Fundoplication.

Authors:  Corey S Johnson; Brian E Louie; Aaron Wille; Christy M Dunst; Stephanie G Worrell; Steven R DeMeester; Jessica Reynolds; Joe Dixon; John C Lipham; Michal Lada; Jeffrey H Peters; Thomas J Watson; Alexander S Farivar; Ralph W Aye
Journal:  J Gastrointest Surg       Date:  2015-03-05       Impact factor: 3.452

Review 6.  Radiofrequency ablation for Barrett's dysplasia: past, present and the future?

Authors:  Rehan Haidry; Laurence Lovat; Prateek Sharma
Journal:  Curr Gastroenterol Rep       Date:  2015-03

7.  Effects of preceding endoscopic mucosal resection on the efficacy and safety of radiofrequency ablation for treatment of Barrett's esophagus: results from the United States Radiofrequency Ablation Registry.

Authors:  N Li; S Pasricha; W J Bulsiewicz; R E Pruitt; S Komanduri; H C Wolfsen; G W Chmielewski; F S Corbett; K J Chang; N J Shaheen
Journal:  Dis Esophagus       Date:  2015-06-30       Impact factor: 3.429

8.  Management of Barrett Esophagus Following Radiofrequency Ablation.

Authors:  Craig C Reed; Nicholas J Shaheen
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-07

9.  Durability and predictors of successful radiofrequency ablation for Barrett's esophagus.

Authors:  Sarina Pasricha; William J Bulsiewicz; Kelly E Hathorn; Srinadh Komanduri; V Raman Muthusamy; Richard I Rothstein; Herbert C Wolfsen; Charles J Lightdale; Bergein F Overholt; Daniel S Camara; Evan S Dellon; William D Lyday; Atilla Ertan; Gary W Chmielewski; Nicholas J Shaheen
Journal:  Clin Gastroenterol Hepatol       Date:  2014-05-09       Impact factor: 11.382

10.  Incidence of Esophageal Adenocarcinoma and Causes of Mortality After Radiofrequency Ablation of Barrett's Esophagus.

Authors:  W Asher Wolf; Sarina Pasricha; Cary Cotton; Nan Li; George Triadafilopoulos; V Raman Muthusamy; Gary W Chmielewski; F Scott Corbett; Daniel S Camara; Charles J Lightdale; Herbert Wolfsen; Kenneth J Chang; Bergein F Overholt; Ron E Pruitt; Atilla Ertan; Srinadh Komanduri; Anthony Infantolino; Richard I Rothstein; Nicholas J Shaheen
Journal:  Gastroenterology       Date:  2015-08-29       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.